FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

Allogeneic HCT has been increasingly used in the setting of FLT3 mutated AML. However, its role in conferring durable relapse-free intervals remains in question. Herein, we sought to investigate FLT3 mutational status on transplant outcomes. We conducted a retrospective cohort study of 262 consecuti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Bone Marrow Transplant
Main Authors: Song, Yeohan, Magenau, John, Li, Yumeng, Braun, Thomas, Chang, Lawrence, Bixby, Dale, Hanauer, David A., Chughtai, Komal A., Gatza, Erin, Couriel, Daniel, Goldstein, Steven, Pawarode, Attaphol, Reddy, Pavan, Riwes, Mary, Connelly, James, Harris, Andrew, Kitko, Carrie, Levine, John, Yanik, Greg, Parkin, Brian, Choi, Sung Won
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720584/
https://ncbi.nlm.nih.gov/pubmed/26191952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2015.170
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki